Liaoning Chengda Biotechnology Co., Ltd. (SHA:688739)
China flag China · Delayed Price · Currency is CNY
20.01
-0.22 (-1.09%)
At close: Nov 17, 2026

SHA:688739 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
2,1014,3654,4964,5485,7972,829
Short-Term Investments
--30.1260.19291.13270.72
Trading Asset Securities
3,143850.47973.021,094-3,316
Cash & Short-Term Investments
5,2445,2155,5005,7026,0886,416
Cash Growth
3.44%-5.17%-3.55%-6.33%-5.12%194.49%
Accounts Receivable
1,1611,0491,0771,0821,111958.17
Other Receivables
2.141.871.4111.911.631.09
Receivables
1,1641,0511,0781,0941,113959.27
Inventory
491.91474.39459.94422.42479.88385.16
Prepaid Expenses
-----2.02
Other Current Assets
42.9246.3145.4730.125.1534.75
Total Current Assets
6,9436,7877,0837,2497,7067,798
Property, Plant & Equipment
1,7931,8771,9611,8851,4371,228
Long-Term Investments
202.85171.14132.37225.07258.56305.31
Other Intangible Assets
807.36182.02181.45178.87187.21123.35
Long-Term Deferred Tax Assets
43.6834.1635.7242.3930.2925.08
Long-Term Deferred Charges
6.6632.09588.54381.37187.4582.06
Other Long-Term Assets
15.8463.269.22120.21249.49231.61
Total Assets
9,8129,74610,05210,08110,0569,793

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
168.0712.195.2215.7616.333.1
Accrued Expenses
91.25178.91189.18158.48165.97176.43
Current Portion of Leases
6.134.65.144.864.534.49
Current Income Taxes Payable
32.23--26.9918.8624.17
Current Unearned Revenue
7.071.643.651.970.163.1
Other Current Liabilities
4.91103.3190.12148.7367.1277.72
Total Current Liabilities
309.66300.63393.31356.79272.99289.01
Long-Term Leases
5.064.771015.1417.421.91
Long-Term Unearned Revenue
67.5575.2785.6100.79111.1120.74
Long-Term Deferred Tax Liabilities
0.140.160.199.54.669.03
Other Long-Term Liabilities
7.6311.210.010.010.010.02
Total Liabilities
390.05392.05489.12482.23406.16440.72

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
416.45416.45416.45416.45416.45416.45
Additional Paid-In Capital
5,0345,0345,0345,0345,0345,034
Retained Earnings
4,1214,0644,2624,2484,1993,901
Treasury Stock
-169.98-160.78-149.99-99.99--
Shareholders' Equity
9,4229,3549,5629,5999,6509,352
Total Liabilities & Equity
9,8129,74610,05210,08110,0569,793

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
11.199.3715.1420.0121.9326.41
Net Cash (Debt)
5,2335,2065,4845,6826,0666,390
Net Cash Growth
3.46%-5.08%-3.48%-6.33%-5.07%193.28%
Net Cash Per Share
12.7912.6413.2813.6614.5316.75
Filing Date Shares Outstanding
410.81411.25411.64412.86416.45416.45
Total Common Shares Outstanding
410.81411.25411.64413.47416.45416.45
Working Capital
6,6336,4866,6906,8927,4337,509
Book Value Per Share
22.8922.7523.2323.2223.1722.46
Tangible Book Value
8,5949,1729,3819,4209,4629,229
Tangible Book Value Per Share
20.9222.3022.7922.7822.7222.16
Buildings
-1,096992.14912.41713.81663.04
Machinery
-1,4921,4351,274880.16867.47
Construction In Progress
-427.4465.58438.82454.03210.84